TREATMENT WITH PSILOCYBIN FOR CHRONIC NEUROPATHIC PAIN AND DEPRESSION (TRANSCEND): AN OPEN-LABEL CLINICAL TRIAL

Registry ID

179-2023

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CENTRE FOR ADDICTION AND MENTAL HEALTH

Start date

2025-02-03

Last update

2024-05-28

Conditions

• TREATMENT RESISTANT DEPRESSION
• NEUROPATHIC PAIN

Related clinical trials

• COMBINING KETAMINE WITH DIALECTICAL BEHAVIOURAL THERAPY (DBT) FOR SUICIDALITY IN INDIVIDUALS WITH TREATMENT RESISTANT DEPRESSION AND BORDERLINE PERSONALITY DISORDER: A PHASE II RANDOMIZED, MIDAZOLAM-CONTROLLED CLINICAL TRIAL (KET-DBT)
• ECSTASY TO ALLEVIATE SEVERE CHRONIC NEUROPATHIC PAIN (EASE PAIN) TRIAL: A RANDOMIZED CONTROLLED PILOT TRIAL
• PSILOCYBIN-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION IN BIPOLAR II DISORDER: A RANDOMIZED CONTROLLED TRIAL
• PHASE 2, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF REPEATED DOSES OF VLS-01 BUCCAL FILM IN PARTICIPANTS WITH TREATMENT RESISTANT DEPRESSION
• PSILOCYBIN FOR TREATMENT-RESISTANT DEPRESSION IN AUTISM: A PILOT TRIAL WITH PRE-POST BRAIN AND COGNITIVE MEASUREMENT TO UNDERSTAND MECHANISMS (PAT-DA)
• PSILOCYBIN FOR ENHANCED ANALGESIA IN CHRONIC NEUROPATHIC PAIN: A RANDOMIZED CONTROLLED PILOT TRIAL (PEACE-PAIN)

View on source registry